|
1
|
Yanai Y, Yokoi C, Watanabe K, Akazawa N and Akiyama J: Endoscopic resection for gastrointestinal tumors (esophageal, gastric, colorectal tumors): Japanese standard and future prospects. Glob Health Med. 3:365–370. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M and Miyata Y: Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 3 (Suppl 1):S67–S70. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Murakami K, Muro K, Numasaki H, Oyama T, Ozawa S, et al: Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus. 19:1–26. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ito Y, Miyashiro I, Ito H, Hosono S, Chihara D, Nakata-Yamada K, Nakayama M, Matsuzaka M, Hattori M, Sugiyama H, et al: Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci. 105:1480–1486. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Koterazawa Y, Nakamura T, Oshikiri T, Kanaji S, Tanaka S, Ishida T, Yamashita K, Matsuda T, Morita Y, Suzuki S and Kakeji Y: A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg Today. 48:783–789. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
van den Boorn HG, Stroes CI, Zwinderman AH, Eshuis WJ, Hulshof MCCM, van Etten-Jamaludin FS, Sprangers MAG and van Laarhoven HWM: Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 154(103069)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kato K, Ito Y, Nozaki I, Daiko H, Kojima T, Yano M, Ueno M, Nakagawa S, Takagi M, Tsunoda S, et al: Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology. 161:1878–1886.e2. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, et al: Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2-3 Nany M0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 57:425–433. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Matsumoto A and Sano T: Salvage esophagectomy after definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: Who really benefits from this high-risk surgery? Ann Surg Oncol. 22:4438–4444. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M and Doki Y: Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol. 100:442–446. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hombu T, Yano T, Hatogai K, Kojima T, Kadota T, Onozawa M, Yoda Y, Hori K, Oono Y, Ikematsu H and Fujii S: Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER? Dig Endosc. 30:338–346. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Koizumi S, Jin M, Matsuhashi T, Tawaraya S, Watanabe N, Sawaguchi M, Kanazawa N, Yamada Y, Onochi K, Kimura Y, et al: Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. Gastrointest Endosc. 79:348–353. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ego M, Abe S, Nakatani Y, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Kato K, Honma Y, Itami J, et al: Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy. Surg Endosc. 35:1766–1776. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Didamson OC and Abrahamse H: Targeted photodynamic diagnosis and therapy for esophageal cancer: Potential role of functionalized nanomedicine. Pharmaceutics. 13(1943)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yano T, Kasai H, Horimatsu T, Yoshimura K, Teramukai S, Morita S, Tada H, Yamamoto Y, Kataoka H, Kakushima N, et al: A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget. 8:22135–22144. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yagi K, Toriumi T, Aikou S, Yamashita H and Seto Y: Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Ann Gastroenterol Surg. 5:436–445. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yano T and Muto M: Photodynamic therapy for esophageal cancer. Gastroenterol Endosc. 59:2740–2749. 2017.
|
|
18
|
Yamaguchi N, Isomoto H, Nakayama T, Hayashi T, Nishiyama H, Ohnita K, Takeshima F, Shikuwa S, Kohno S and Nakao K: Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc. 73:1115–1121. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, et al: Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 12:1–30. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yamashita H, Kadota T, Minamide T, Sunakawa H, Sato D, Takashima K, Nakajo K, Murano T, Shinmura K, Yoda Y, et al: Efficacy and safety of second photodynamic therapy for local failure after salvage photodynamic therapy for esophageal cancer. Dig Endosc. 34:488–496. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ishihara R, Arima M, et al: ESD/EMR guidelines for esophageal cancer. Gastroenterol Endosc. 62:223–271. 2020.PubMed/NCBI View Article : Google Scholar : (In Korean).
|
|
22
|
Yoshii T, Ohkawa S, Tamai S and Kameda Y: Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer. Dis Esophagus. 26:496–502. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Takahashi K, Hashimoto S, Mizuno KI, Kobayashi T, Tominaga K, Sato H, Kohisa J, Ikarashi S, Hayashi K, Takeuchi M, et al: Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma. Endoscopy. 50:662–670. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A and Ogino T: Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol. 92:266–269. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Minashi K, Nihei K, Ogawa G, Takizawa K, Yano T, Amanuma Y, Tsuchida T, Ono H, Iizuka T, Shichijyo S, et al: Final analysis of single-arm confirmatory study of diagnostic endoscopic resection (ER) plus selective chemoradiotherapy (CRT) for stage I esophageal squamous cell carcinoma (ESCC): JCOG0508. J Clin Oncol. 36(4023)2018.
|
|
26
|
Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T and Yoshida S: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 21:2697–2702. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yano T, Muto M, Minashi K, Ohtsu A and Yoshida S: Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc. 62:31–36. 2005.PubMed/NCBI View Article : Google Scholar
|
